Viewing Study NCT03266692


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-01-16 @ 6:51 AM
Study NCT ID: NCT03266692
Status: TERMINATED
Last Update Posted: 2020-03-30
First Post: 2017-08-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor: Cogent Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module